Literature DB >> 11906818

ATPase pumps in osteoclasts and osteoblasts.

Martin J O Francis1, Rita L Lees, Elisa Trujillo, Pablo Martín-Vasallo, Johan N M Heersche, Ali Mobasheri.   

Abstract

Osteoblasts, osteocytes and osteoclasts are specialised cells of bone that play crucial roles in the formation, maintenance and resorption of bone matrix. Bone formation and resorption critically depend on optimal intracellular calcium and phosphate homeostasis and on the expression and activity of plasma membrane transport systems in all three cell types. Osteotropic agents, mechanical stimulation and intracellular pH are important parameters that determine the fate of bone matrix and influence the activity, expression, regulation and cell surface abundance of plasma membrane transport systems. In this paper the role of ATPase pumps is reviewed in the context of their expression in bone cells, their contribution to ion homeostasis and their relation to other transport systems regulating bone turnover.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11906818     DOI: 10.1016/s1357-2725(01)00142-x

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  15 in total

1.  Association between low C-peptide and fragility fractures in postmenopausal women without diabetes.

Authors:  Y Ferro; C Russo; D Russo; C Gazzaruso; A Coppola; P Gallotti; V Zambianchi; M Fodaro; S Romeo; E Galliera; M G Marazzi; M M C Romanelli; S Giannini; A Pujia; T Montalcini
Journal:  J Endocrinol Invest       Date:  2017-04-11       Impact factor: 4.256

2.  Anoctamin-6 controls bone mineralization by activating the calcium transporter NCX1.

Authors:  Jiraporn Ousingsawat; Podchanart Wanitchakool; Rainer Schreiber; Manuela Wuelling; Andrea Vortkamp; Karl Kunzelmann
Journal:  J Biol Chem       Date:  2015-01-14       Impact factor: 5.157

Review 3.  The vacuolar ATPase in bone cells: a potential therapeutic target in osteoporosis.

Authors:  Feng-Lai Yuan; Xia Li; Wei-Guo Lu; Cheng-Wan Li; Jian-Ping Li; Yu Wang
Journal:  Mol Biol Rep       Date:  2010-02-25       Impact factor: 2.316

4.  RANKL up-regulates brain-type creatine kinase via poly(ADP-ribose) polymerase-1 during osteoclastogenesis.

Authors:  Jianfeng Chen; Yong Sun; Xia Mao; Qizhan Liu; Hui Wu; Yabing Chen
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

5.  Nanohydroxyapatite shape and its potential role in bone formation: an analytical study.

Authors:  Priya Kalia; Gema Vizcay-Barrena; Jian Ping Fan; Alice Warley; Lucy Di Silvio; Jie Huang
Journal:  J R Soc Interface       Date:  2014-01-29       Impact factor: 4.118

Review 6.  Phosphate: known and potential roles during development and regeneration of teeth and supporting structures.

Authors:  Brian L Foster; Kevin A Tompkins; R Bruce Rutherford; Hai Zhang; Emily Y Chu; Hanson Fong; Martha J Somerman
Journal:  Birth Defects Res C Embryo Today       Date:  2008-12

7.  Association between low C-peptide and low lumbar bone mineral density in postmenopausal women without diabetes.

Authors:  T Montalcini; P Gallotti; A Coppola; V Zambianchi; M Fodaro; E Galliera; M G Marazzi; S Romeo; S Giannini; M M Corsi Romanelli; A Pujia; C Gazzaruso
Journal:  Osteoporos Int       Date:  2015-01-24       Impact factor: 4.507

Review 8.  The Role of Osteoclast Energy Metabolism in the Occurrence and Development of Osteoporosis.

Authors:  Wacili Da; Lin Tao; Yue Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-12       Impact factor: 5.555

9.  Differential regulation of HIF-mediated pathways increases mitochondrial metabolism and ATP production in hypoxic osteoclasts.

Authors:  Karl J Morten; Luned Badder; Helen J Knowles
Journal:  J Pathol       Date:  2013-04       Impact factor: 7.996

10.  Accelerated Lactate Dehydrogenase Activity Potentiates Osteoclastogenesis via NFATc1 Signaling.

Authors:  Heejin Ahn; Kyunghee Lee; Jin Man Kim; So Hyun Kwon; Seoung Hoon Lee; Soo Young Lee; Daewon Jeong
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.